
How to Choose Between Kisunla vs. Leqembi, The New Alzheimer’s Drugs
The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?
The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?
In dementia, people repeatedly ask, “What’s the time?” “What day is it?” Easily solve this with Dementia-clocks / Calendar-clocks. Check out 7 clocks with good looks and limitless patience.
Stanford Medicine’s new analysis of a vaccination program found shingles vaccines appear to lower dementia diagnoses by 20% — more than any other known intervention.
Tau and amyloid are the two culprits behind Alzheimer’s. Biogen gave the world Leqembi to treat amyloid. Now, learn how Biogen’s Investigational Tau-Targeting Therapy BIIB080 just received FDA Fast Track Designation.
Interestingly, loving care does not require twice the time. But it does require twice the presence.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.